HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Miral Dizdaroglu Selected Research

8-hydroxyadenine

8/2004Cellular repair of oxidatively induced DNA base lesions is defective in prostate cancer cell lines, PC-3 and DU-145.
4/2003Primary fibroblasts of Cockayne syndrome patients are defective in cellular repair of 8-hydroxyguanine and 8-hydroxyadenine resulting from oxidative stress.
8/2002The cockayne syndrome group B gene product is involved in cellular repair of 8-hydroxyadenine in DNA.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Miral Dizdaroglu Research Topics

Disease

19Neoplasms (Cancer)
01/2021 - 03/2002
8Carcinogenesis
01/2019 - 06/2002
7Breast Neoplasms (Breast Cancer)
09/2015 - 06/2006
3Cockayne Syndrome (Syndrome, Cockayne)
04/2009 - 08/2002
2Inflammation (Inflammations)
01/2019 - 12/2018
2Hepatocellular Carcinoma (Hepatoma)
01/2019 - 01/2019
2Photosensitivity Disorders (Photodermatitis)
12/2008 - 12/2008
2Xeroderma Pigmentosum (Kaposi's Disease)
09/2007 - 09/2006
1Glomerulonephritis
01/2021
1Chronic Disease (Chronic Diseases)
11/2020
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
11/2020
1Hepatitis B
01/2019
1Infections
01/2019
1Pneumonia (Pneumonitis)
12/2018
1Bipolar Disorder (Manic Depressive Psychosis)
01/2018
1Prediabetic State (Prediabetes)
12/2016
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2012
1Atherosclerosis
03/2012
1Metabolic Syndrome (Dysmetabolic Syndrome X)
12/2008
1Lung Neoplasms (Lung Cancer)
06/2005
1Prostatic Neoplasms (Prostate Cancer)
08/2004
1Hypoxia (Hypoxemia)
09/2003

Drug/Important Bio-Agent (IBA)

21DNA (Deoxyribonucleic Acid)IBA
01/2021 - 03/2002
9Proteins (Proteins, Gene)FDA Link
01/2016 - 04/2009
8Biomarkers (Surrogate Marker)IBA
01/2019 - 06/2010
5DNA Glycosylases (DNA Glycosylase)IBA
01/2021 - 12/2008
58-hydroxyguanineIBA
10/2015 - 03/2002
4IsotopesIBA
01/2018 - 03/2012
48-Hydroxy-2'-DeoxyguanosineIBA
12/2016 - 12/2006
32,6- diamino- 4- hydroxy- 5- formamidopyrimidineIBA
12/2008 - 06/2007
34,6-diamino-5-N-formamidopyrimidine (FAPy)IBA
12/2008 - 06/2007
38-hydroxyadenineIBA
08/2004 - 08/2002
2Aflatoxin B1 (Aflatoxin B)IBA
01/2019 - 01/2019
2Reactive Oxygen Species (Oxygen Radicals)IBA
12/2016 - 03/2002
2EnzymesIBA
10/2015 - 08/2004
2Pharmaceutical PreparationsIBA
12/2012 - 09/2003
2Free RadicalsIBA
04/2012 - 11/2011
2Hydroxyl RadicalIBA
12/2008 - 12/2008
2AntioxidantsIBA
12/2005 - 08/2004
1Antinuclear AntibodiesIBA
01/2021
1DNA AdductsIBA
01/2019
1AflatoxinsIBA
01/2019
1NucleosidesIBA
01/2018
1DNA Repair EnzymesIBA
01/2018
1AS 8IBA
12/2016
1hydroxide ionIBA
12/2016
1EndonucleasesIBA
09/2015
1Tumor Biomarkers (Tumor Markers)IBA
12/2012
1RNA (Ribonucleic Acid)IBA
08/2012
1Oxygen (Dioxygen)IBA
11/2011
1GATIBA
07/2009
1Codon (Codons)IBA
07/2009
1A-Form DNA (A-DNA)IBA
06/2007
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
06/2007
18-hydroxy-2'-deoxyadenosineIBA
06/2007
1OligonucleotidesIBA
12/2006
1Messenger RNA (mRNA)IBA
06/2005
1GuanineIBA
06/2005
1thymine glycolIBA
08/2004
1CatalaseIBA
08/2004
1Superoxides (Superoxide)IBA
08/2004
1Glutathione PeroxidaseIBA
08/2004
15-hydroxycytosineIBA
08/2004
1Tirapazamine (SR 4233)IBA
09/2003
1PurinesIBA
03/2002

Therapy/Procedure

8Therapeutics
01/2021 - 12/2012